Showing results (231-240 of 503) with videos related to
Sort By:
Pageof 51
Dermatologic Therapy|October 14, 2019
Efficacy and safety of Vismodegib treatment in patients with advanced basal cell carcinoma and multiple comorbiditiesGiulia Spallone, Pietro Sollena, Alessandra Ventura, et al.Future Oncology (London, England)|February 17, 2015
Identifying locally advanced basal cell carcinoma eligible for treatment with vismodegib: an expert panel consensusKetty Peris, Lisa Licitra, Paolo A Ascierto, et al.Dermatology Practical & Conceptual|August 12, 2025
Clinical and Ultrasonographic Assessment of Nail Psoriasis: A Comprehensive StudyMaria Esposito, Lina Maria Magnanimi, Paolo Antonetti, et al.Diseases (Basel, Switzerland)|July 25, 2025
Efficacy of Dupilumab in a Young Woman with Refractory Cutaneous Lichen Planus: A Case-Based ReviewCristina Guerriero, Luisa Boeti, Francesco Mastellone, et al.Advances in Therapy|November 15, 2024
Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature ReviewMariateresa Rossi, Silvia M Ferrucci, Piergiacomo Calzavara-Pinton, et al.Expert Opinion on Biological Therapy|February 10, 2025
Literature review and expert opinion on diagnosis and current management of generalized pustular psoriasisAngelo Valerio Marzano, Maria Concetta Fargnoli, Paolo Gisondi, et al.Cancers|November 27, 2024
Impact of COVID-19 Pandemic on Delay of Melanoma Diagnosis: A Systematic Review and Meta-AnalysisCristina Pellegrini, Saverio Caini, Aurora Gaeta, et al.Acta Dermato-Venereologica|November 28, 2019
Intra-patient Heterogeneity of BRAF and NRAS Molecular Alterations in Primary Melanoma and MetastasesCristina Pellegrini, Ludovica Cardelli, Marina De Padova, et al.Cancers|October 27, 2022
Defining the Profile of Patients with Primary Merkel Cell Carcinoma in Central Italy: A Retrospective AnalysisGiulio Gualdi, Gerardo Ferrara, Marco Simonacci, et al.Familial Cancer|July 3, 2021
Novel MAPK/AKT-impairing germline NRAS variant identified in a melanoma-prone familyKevin M Brown, Mai Xu, Michael Sargen, et al.Pageof 51